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Summary 
During persistent infection of scid mice with Borrelia turicatae, an agent of relapsing fever and 
neuroborreliosis, there was variation in the surface proteins the bacteria expressed and in disease 
manifestations over time. Two serotypes, A and B, were isolated from the mice, doned by limiting 
dilution, and further characterized. The only discernible difference between the two variants 
was in the size of the major surface protein they expressed: serotype A had a variable major 
protein (Vmp) of 23,000, and serotype B had a Vmp of 20,000. When other scid mice were 
inoculated with clonal populations of A and B, the infections were similar with respect to onset 
and degree of spirochetemia, nvolvement of the eye and heart, and occurrence of a peripheral 
vestibular disorder. However, there were differences between the serotypes in other espects: (a) 
serotype B but not A caused reddened and significantly enlarged joints, markedly impaired 
performance on a walking bar, and severe arthritis by histologic examination; (b) serotype A
but not B invaded the central nervous ystem during early infection; and (c) serotype A penetrated 
monolayers of human umbilical vein endothdial cells more readily than did serotype B. The 
combination ofarthritis, myocarditis, and neurologic disease resembled human Lyme borreliosis. 
The findings indicate that differences in disease xpression are determined by variable surface 
proteins of the bacterium and that scid mouse infections with R turicatae provide a model for 
the study of the pathogenesis of Lyme borreliosis and other persistent spirochetal diseases. 
D uring Lyme borreliosis there is sequential involvement over weeks to years of different organs, including heart, 
joints, central and peripheral nervous ystems, and eyes (1). 
Although viable bacteria dearly initiate disease, the host's 
immune response to the agent determines in part the severity 
of that disease (2-4). To further delineate the relative contri- 
butions of parasite and host in this pathogenesis equation 
an animal model would be hdpful. Infections with Borrelia 
burgdorferi, the agent of Lyme borrdiosis, have been estab- 
lished in laboratory animals, including mouse, rat, hamster, 
rabbit, and gerbil (5-9). In both immunocompetent a dim- 
munocompromised animals these infections have involved the 
joints and heart, but there has been little or no evidence of 
disease of the nervous ystem in these animal models. Infec- 
tion of the brain by/g burgdorferi is inconsistent and short- 
lived, even in immunodeficient animals (5, 6, 10, 11). 
A closely related group of spirochetes inthe genus Borrel/a 
cause relapsing fever (12). The two principal species that pro- 
duce disease in North America are R herrnsii and/g turicatae 
(13). The infection of both humans and experimental animals 
is characterized by periodic illness of the host and antigenic 
variation of the etiologic spirochete inthe blood (14). A fea- 
ture of relapsing fever that is less appreciated now than in 
the past is the involvement of the nervous ystem in human 
infections (15, 16). Several decades ago investigators first noted 
that certain strains ofrdapsing fever borrelias were neurotropic 
(17, 18). The specific phenomenon that these arlier investi- 
gators noted was the propensity of some but not all strains 
of borrelias to invade the nervous tissue and persist here for 
weeks to years (19, 20). Neurotropism was observed not only 
in laboratory animals but in the vector ticks as well (21). 
Relapsing fever borrelia strains have a large repertoire of pro- 
teins to display on their surface (22), and therefore it was 
possible that the neurotropic potential within a strain was 
conferred by one or more of these variable proteins. 
The original goal of the study was to establish persistent 
infection by a Borrelia species of the brain of a laboratory an- 
imal. This aim was achieved, but as notable were the findings 
631 J. Exp. Med. @ The Rockefeller University Press 9 0022-1007/94/02/0631/12 $2.00 
Volume 179 February 1994 631--642 
that some variants ofR turicatae are neurotropic and that there 
were differences in disease xpression with different variants. 
Most surprising was the similarity of the disease we observed 
in infected mice to systemic Lyme borreliosis of humans. 
Mater iah  and Methods 
Strains and Culture Conditions. R turicatae was isolated by in- 
jecting Swiss mice with tissues from Ornithodoros turicata collected 
in a cave near Ozona, TX (23). R hermsii strain HS1 (35209; Amer- 
ican Type Culture Collection, Rockville, MD) and Spirochaeta 
aurantia strain M1 have been described previously (24, 25). Borrelias 
were cultured in BSK II medium with 12% rabbit serum (26), and 
& aurantia was grown in YT medium (25). When tissue samples 
were cultured, rifampin at 50 ~g/ml and phosphomycin at 100 
~g/ml were present in the medium. Intrastrain borrelia variants 
with different variable major proteins (Vmp's) 1were designated by 
convention "serotypes" and, to distinguish the Vmp's from those 
ofR hermsii, they were also designated by letters instead of numbers 
(22). Serotypes were cloned by limiting dilution in BALB/c mice 
(Harhn Laboratories, Indianapolis, IN) irradiated with 650 tad from 
a ~TCs gamma source (24). Plasma samples from infected mice 
were either frozen with 10% DMSO at -80~ or used to start 
broth cultures, which at cell densities of 10Vml were aliquoted 
and similarly frozen until use. Spirochetes were counted in a Petroff- 
Hanser chamber under phase contrast microscopy (24). 
Protein and Nucleic Acid Analysis. Whole cells from harvested 
cultures were subjected to SDS-PAGE with 12.5 or 14% acrylamide 
(22). Surface-exposed proteins of intact borrelias were cleaved with 
proteinase K (Boehringer Manaheim Corp., Indianapolis, IN) and 
examined by PAGE as descn'bed (27). Total DNA was obtained from 
the borrelias, digested with restriction enzymes, and subjected to 
agarose gd dectrophoresis a described (28). 
Monolayer Penetration Assay. Spirochetes in late-log phase cul- 
tures were harvested by centrifugation (5 min at 7,000 g) and after 
washing, adjusted to 109 cells/m1 in M199 medium (Gibco Labora- 
tories, Grand Island, NY) containing 20% FCS. Human umbilical 
vein endothelial cells were isolated from freshly ddivered umbilical 
cords by the method ofJaffe et al. (29). The cells were maintained 
in an atmosphere of 5% CO2 in air at 370C in M199 medium, 
100/~g/ml of heparin, and 50 ng/ml of endothelial cell growth 
supplement (Gibco Laboratories). Confirmation of endothelial cell 
character and penetration assays were conducted as previously de- 
scribed (30). Briefly, 2.5 x 104 endothelial cells were seeded onto 
3-~m pore size, 6.5-ram diameter sterile polycarbonate membrane 
culture plate inserts (Nucleopore, Pleasanton, CA). Chambers were 
placed in 24-wdl plates containing 1 re_l/well M199 with FCS. After 
incubation for 48 h, the monolayers were confluent, and high trans- 
endothelial resistance was confirmed; aliquots of 108 spirochetes 
in 0.2 ml medium were ~_dd~ to the upper portions of the chambers. 
At different times of incubation, aliquots from beneath the filter 
were removed, and spirochetes were directly counted as described 
above. The assay was performed three times. 
Mouse Infections. 4-6-wbold female BALB/c mice (Harlan 
Laboratories) ormale CB-17 scid mice (Charles River Laboratories, 
Wilmington, M_A) were inocuhted intraperitoneally or intracere- 
brally with borrelia suspensions in 300 and 60/~1 of PBS, respec- 
tively. Control mice received PBS alone, sad mice were maintained 
in a germ-frec environment before and after infection. For evalua- 
t Abbreoiations u ed in this paper: CI, confidence interval; Vmp, variable 
major protein. 
tion of spirochetemia, tail vein blood was mixed with an equal 
volume of PBS and examined by phase contrast microscopy. The 
mice were examined affy, and presence of these signs were 
specifically noted: ruffled fur, eye discharge, reddened joints, head 
tilt, spinning in the air when lifted off the ground by the tail, and 
walking in circles (31). Abnormal signs were confirmed by an ob- 
server who did not know whether the mouse was infected or not. 
The sizes of the tibiotarsal joints and metatarsal regions at their 
greatest diameter were measured with a vernier caliper. Mouse sera 
were examined for anti-borrelia ntibodies by indirect im- 
munofluorescence as previously described (22). 
Beam Walking Test. The mice were trained on a stationary 
horizontal beam 48 and 24 h before test trials (32). The Plexiglas 
beam measured 120 (length) x 1.2 (thickness) x 0.7 (width) cm, 
had phtforms at both ends, and was at a 50 cm height. Test trials 
consisted in three complete crossings of the beam. For every crossing 
two determinations were made: traversing time in seconds and the 
number of times one of the hind feet slipped off the beam. 
Tissue and Fluid Collection. Mice were killed with methoxy- 
flurane. Sodium citrate was used as an anticoagulant for blood col- 
lection by heart puncture. Total body peffusion with 30 ml PBS 
was performed as described (33). After the skull was opened under 
sterile conditions, brain tissue was removed and rinsed twice with 
1 ml of PBS in sterile 2-ml microfuge tubes (Sarstedt Inc., Newton, 
NC). To the brain tissue sample was added twice its volume of 
BSK II medium. With plungers of sterile 1-ml plastic syringes 
(Becton Dickinson & Co., Mountain View, CA) the brain tissue 
was homogenized in the tubes and then suspended in medium by 
briefly vortexing. Blood and brain suspensions were centrifuged 
for 5 s at 7,000 g. If red blood calls were observed microscopically 
in the brain suspension or as a layer in the brain pellet, the sample 
was discarded. Eyes and fibiotarsaljoints were removed, rinsed with 
sterile PBS, and then added en block to culture tubes (34). Samples 
from uninfected mice were processed as negative controls for cross 
contamination between mice during procedures. All cultures were 
examined for a 3-wk period. 
HistopathologicalStudies. Internal organs inclnding brain, heart, 
and testis and different joints of mice were removed after total body 
perfusion with buffer. Tissues were immersion fixed in 10% neu- 
tral buffered formalin. The bones were decalcified in 5% nitric acid 
after fixation. Hematoxylin and eosin-stained slides were prepared 
by standard histologic methods. The slides were read by a veteri- 
nary pathologist (K. Crawley) without prior knowledge of which 
animals were infected and, if infected, with which serotype. The 
amount of inflammation i cardiac and synovial tissues was graded 
as none, mild, moderate, or severe. The criteria for grading arthritis 
were the following: mild, focal inflammation ofsynovial membrane 
with minimal exudation into joint space or periarticular tissues; 
moderate, coalescing areas of inflammation i the synovial mem- 
branes with moderate exudation into the joint space or periartic- 
ular tissues; and severe, inflammation of synovial membrane in- 
volving the entire joint with marked exudation i to the joint space 
and periarticular tissues. The criteria for grading carditis were the 
following: mild, multifocal but nonconfluent leukocytic accumu- 
lation in myocardial or pericardial tissues; moderate, multifocal leu- 
kocytic accumulations that were confluent in some areas; and se- 
vere, largely confluent or transmural areas of inflammation. 
Results 
Isolation of Serot),pes A and R The present study began 
as an attempt to find an animal model of spirochete infection 
in which persistent infection of the brain occurred. We had 
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shown previously that R hermsii nvades the central nervous 
system of mice (33). However, after a preliminary stud  showed 
that R hermsii nfections of the brain of BALB/c mice did 
not last beyond 2 wk, we considered other Borrel/a species. 
Previous reports had indicated that among the r lapsing fever 
Borrel/a species, R turicatae was often associated with neuro- 
logic disease in humans (16). The Ozona strain of this spe- 
des was implicated in an outbreak of relapsing fever, which 
was first hought o be Lyme disease on the basis of cranial 
neuritis (23). Using BALB/c mice we first documented the 
invasion of the brain by the Ozona strain ofR turicatae. Four 
mice were inoculated intraperitoneally with 103 borrelias on 
day 0. Borrelias were microscopically detectable in or cultiv- 
able from the blood in two mice examined on day 10 but 
not in mice examined on days 24 and 31. In contrast, the 
perfused brain contained cultivable R turicatae on days 24 and 
31 as well as 10. With the exception of ruffled fur when 
spirochetemic, the infected mice did not appear to be ill. 
Different results were obtained with two scid mice who 
were given the same inoculum and similarly examined for
blood and brain infection at various times. The mice had 
spirochetemia at all examinations and, in addition to ruffled 
fur, had a self-limited mucopurulent discharge from the eyes 
early in the infection. The PAGE profiles from brain and plasma 
isolates obtained from one mouse xamined on day 7 and from 
the other mouse xamined on days 50 and 100 are shown 
in Fig. 1, 1~/. Isolates from the plasma nd brain of the mouse 
examined on day 7 were identical to one another but differed 
from isolates taken from the mouse xamined on days 50 and 
100. The differences between isolates were in major proteins 
with apparent Mr of20,000-35,000 (35 K). Day 7 brain and 
plasma isolates had major proteins of 33, 22, and 21 K not 
present in the other isolates. Later isolates uniquely had ei- 
ther or both proteins of 23 and 20 K. Days 50 and 100 blood 
populations from the second mouse produced both proteins, 
albeit less of the 23 K protein by day 100 (Fig. 1). In con- 
trast, the brain isolate from day 100 detectable produced only 
the 23 K Vmp protein. 
Characterization f Serotypes A and R This experiment i - 
dicated that even in immunoddicient mice variation of major 
proteins of a relapsing fever bo rdia occurred over time. Fur- 
thermore, populations of borrelias in the brain and blood of 
the same animal differed, the implication being that some 
isolates are more neurotropic than others. If this was the case, 
then one would expect in a prospective study that the variant 
expressing the 23K protein would more likely infect the brain 
than the variant population expressing predominantly he 20 
K protein. For evaluation of this hypothesis donal popula- 
tions of the two variants were needed. These were obtained 
by cloning by limiting dilution in irradiated mice. First pas- 
sage cultures of the clonal populations were characterized with 
respect to profiles of their total proteins and restriction en- 
zyme digests, growth rate, infectivity, and in vitro invasive- 
ness. The phenotypes that are described below for the two 
clones were stable after further passage inboth broth medium 
and scid mice. 
Fig. 1, right, shows the total cellular proteins of the two 
Figure 1. Coomasie blue-stained proteins in whole cell lysates ofiso- 
lates ofR turicatae. The migrations of molecular weight standards (x 1,000) 
are shown on the left. (Left) 14% acrylamide gel of brain (b) and plasma 
(p) isolates from days 7, 50, and 100 of sc/d mice inoculated with/~ turicatae. 
The p7 and b7 isolates were from ne mouse and the p50, p100, and bl00 
isolates from a second mouse. The arrow indicates a faint protein of 
23 K that is more prominent in the p50 and bl00 hnes. (Right) 12.5% 
acrylamide gel of cloned isolates from bl00 and pl00 populations, now 
designated serotypes A and B, respectively. In the two rightmost lanes 
of this gel the cells had first been treated with proteinase K. The Vmp 
proteins of 23 and 20 K in A and B populations were cleaved by the pro- 
tease. Two ther proteins that were cleaved in situ by the protease and 
were the same in cultures from both populations are indicated byasterisks. 
The upper band is BSA from the medium. 
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clonal populations. The variant expressing the 23 K protein 
was designated serotype A, and this variant-specific protein 
was called VmpA. The corresponding designations for the 
other variant population were serotype B and VmpB. Previous 
studies with R burgdo~ri and R hermsii ndicated that sero- 
typic specificity is largely determined by major proteins of 
20-35 K that are surface xposed (35, 36). When intact, viable 
cells were treated with proteinase K, VmpA and VmpB were 
cleaved from the cells (37), as shown in Fig. 1, and also in 
gels with a higher concentration of acrylamide. Two pro- 
teins common to serotypes A and B were also affected by 
the in situ protease treatment: one of 69 K, which corre- 
sponds to the bovine albumin in the medium, and one of 
65 K (Fig. 1). The latter protein is probably homologous 
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to minor proteins of about he same size of/~ burgdorferi and 
B, hermsii that are likewise cleaved in situ by proteases (38, 
39). There was no detectable difference inthe restriction frag- 
ment profiles ofBgllI, PstI, and HindlII digests of total DNA 
of the two serotypes (data not shown), an indication that 
the two serotypes were substantially isogenic. 
The polymorphic character of Vmp proteins was demon- 
strated in two immunocompetent BALB/c mice inoculated 
with 104 cells of donal populations of serotype A or B. The 
tail vein blood was cultured at the time of the peak spiro- 
chetemia nd relapse spirochetemia, nd the isolates were 
characterized by PAGE (data not shown). In the relapse popu- 
lation of the mouse inoculated with serotype A, VmpA was 
replaced by Vmp's of 37 and 21 K. In the mouse inoculated 
with serotype B the relapse population expressed a Vmp of 
22 K instead of VmpB. 
Serotypes A and B were examined with respect to growth 
rate in culture and infectivity of mice. The mean growth rates 
at 34~ for three determinations (95% confidence intervals 
[95% CI]) for serotypes A and B were 6.9 (5.9-7.9) h and 
7.1 (6.9-7.3) h, respectively. When groups of three irradi- 
ated BALB/c mice each were inoculated intraperitoneally with 
an estimated 103, 101, 10 ~ and 10-1 spirochetes ofserotype 
A or B, the number of infected mice in each group, in order 
of descending inoculum size, were 3, 3, 2, and 0 for serotype 
A and 3, 3, 1, and 0 for serotype B.This indicated that either 
serotype can produce infection with as few as one or two 
cells, as $chuhardt found with another strain of/~ turicatae 
(40). When scid mice were inoculated with 103 cells of ei- 
ther serotype A or B, spirochetes were detectable by daily 
phase contrast microscopy of tail vein blood by day 4. These 
experiments indicated that serotypes A and B had similar ca- 
pacities to grow in culture and to establish infection in mice. 
In an initial study of biological differences between the 
two serotypes, the ability of the spirochetes topass through 
monolayers of human umbilical vein endothelial calls was as- 
sessed. The mean percentage (95% CI) of the number of 
borrelias added to the upper part of the chamber that were 
detected on the other side at 6 h was 10.0 (8.8-11.3) for sero- 
type A, 4.6 (4.1-5.0) for serotype B and 0.7 (0.4-0.9) for 
the nonpathogenic spirochete $. aurantia. 
Differences inDisease in Serotype A-  and B-inoculated Mice. 
The previous findings suggested that/g turicatae serotypes 
A and B, while detectably identical in all respects except in 
the Vmp proteins and ~ vitro invasiveness, might differ in 
the diseases they produced. To assess this scid mice were in- 
fected with the donal Populations of serotypes A or B. Mice 
numbered 1-29 were divided into groups of 4, 12, and 13 
mice, which were injected intraperitoneally with PBS, 103 
serotype A cells, or 103 serotype B cells in PBS, respectively, 
on day 0. From each of the infected groups four to five mice 
were taken on days 4, 11, and 31, and their organs and tissues 
were sampled for culture. All mice were spirochetemic through 
the 31 d of study. There was no difference between A- and 
B-inoculated mice in the spirochete count in the blood at 
any point. 
Fig. 2 summarizes disease xpression i the mice. By day 
8 the eight remaining mice inoculated with serotype A and 
the nine remaining mice inoculated with serotype B were 
listless and had ruffled fur. Mucopurulent discharge from the 
eyes beginning by day 8 and not lasting beyond ay 13 was 
observed inmice infected with either serotype but more com- 
monly in those infected with B. The joints were involved 
next. Tibiotarsaljoint and metatarsal region reddening began 
on day 10, 11, or 12 in all serotype B-inoculated mice but 
not at all in control or serotype A-inoculated mice. The mean 
sizes of the right and left tibiotarsaljoints forcontrol, A-inocu- 
lated, and B-inoculated mice for days 12-31 are shown in Fig. 
3 A. Measurements of the metatarsal regions of these animals 
for days 15-21 are given in Fig. 3 B. The joints of B-inoculated 
mice were significantly larger than those of either control 
or A-inoculated mice. The measurable joint enlargement lasted 
a few days longer than joint reddening evident on eye exami- 
nation (Fig. 2). Joint involvement recurred on day 30 in two 
of five B-inoculated mice (Figs. 2 and 3). 
To confirm an association between joint disorder and sero- 
type B a second group (II) of scid mice (nos. 30-39) were 
inoculated with PBS (n = 2), 103 serotype A cells (n = 4), 
or 103 serotype B cells (n = 4). Joints were measured daily; 
results for days 10-14 are given in Fig. 3 C. Reddened joints 
on days 12-14 were again noted in B-inoculated mice but 
not in control or A-inoculated mice. Tibiotarsal joints of 
B-inoculated mice on days 12-14 were significantly larger than 
joints of control or A-inoculated mice. In group II as well 
as group I, the joints of A-inoculated mice were slightly larger 
than those of control mice. On day 14 the animals were killed 
for culture and histopathologic examination f joints and other 
organs (see below). 
In group I mice signs of an equilibrium disorder began 
on day 19 or later for four of five B-inoculated mice and day 
29 for one of four A-inoculated mice (Fig. 2). The manifesta- 
tions were head tilt, walking in circles in one direction, and 
spinning in the air when lifted off the ground by the tail. 
When deprived of proprioceptive input from the ground, 
the affected animals attempted to achieve asupported posi- 
tion. This disorder, like those of eyes and joints, resolved after 
a few days. There was no evidence of hemiparesis, abnormal 
posture, or involvement of cranial nerves other than VIII 
during the period of examination. 
Assessment of Functional Impairment. Traversing an elevated 
narrow beam assesses both locomotor performance and ves- 
tibular system integrity of rodents (41). After mice in group 
I had first been trained for walking the beam, they were in- 
oculated with PBS, serotype A, or serotype B as described 
above. Traversing times and footslips were measured daily for 
days 1-15 and 29-31 and every other day for days 16-28. Fig. 
4 shows in radar graphs the results with the A- and B-inocu- 
lated and control mice that were followed for 31 d. The results 
obtained with mice examined aily for 4 or 11 d after inocu- 
lation were the same for these time periods as those obtained 
with mice examined for 31 d (data not shown). 
The mean number of foot slips for control mice in 312 
trials was 0.2 per crossing. Only mice infected with serotype 
B had functional impairment by the criterion of number of 
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footslips (Fig. 4). The impairment in B-inoculated mice was 
greatest during days 10-14 and 20-27, the respective periods 
of joint and vestibular disorders. On day 11, when B-inoculated 
but not A-inoculated mice had joint disease, the mean number 
(95% CI) of foot slips was 0.1 (0-0.3) for A-inoculated mice 
and 16 (6-26) for B-inoculated mice. 
Crossing times were more variable within groups (Fig. 4). 
The mean (SD) crossing time for uninfected mice in 312 trials 
was 16 (6) s. Crossing times in A-inoculated mice were lon- 
gest between days 8 and 19, when minimal joint swelling 
occurred, and between days 29 and 31 when one mouse had 
vestibular disorder. Some A-inoculated mice had crossing times 
Table 1. Inflammation of the Joints of scid Mice Infected with B. turicatae Serotypes A or B 
Serotype A 
None* Mild Moderate Severe None 
Scrotype B 
Mild Moderate Severe 
Knees 4 0 0 0 0 0 3 1 
Tibiotarsal 0 2 2 0 0 0 1 3 
Metatarsophalangeal 0 4 0 0 1 2 1 0 
Metacarpophalangeal 1 3 0 0 0 2 1 1 
Elbow 3 1 0 0 0 4 0 0 
Total 8 10 2 0 1 8 6 5 
* See Materials and Methods for criteria. 
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~3 SD greater than the mean for controls. Crossing times 
were longer in B-inoculated mice; only mice in this group 
had crossing times of 75 s or more. On day 12 the mean 
crossing times (95% CI) for A- and B-inoculated mice were 
17 (6-28) and 49 (32-66) s, respectively. As with foot slips, 
the greatest impairment in beam walking for B-inoculated 
mice corresponded to the periods of joint and later of ves- 
tibular disorders. 
Histopathology. Blinded examinations were made on tissues 
of the eight group II mice kiUed on day 15 after inoculation 
and two uninfected scid mice of the same age. Most B-inocu- 
lated mice had reddened, swollen joints at this time, while 
A-inoculated mice had joints that were somewhat larger than 
controls but smaller than those of B-inoculated mice. Table 
1 summarizes histologic findings in the joints of serotype 
A- and B-inoculated mice; control mice did not have any 
detectable inflammation of the joints or tendon sheaths. 8 
of 20 examined joints of A-inoculated mice were normal com- 
pared with 1 of 20 in serotype B-inoculated mice (p <0.01 
by Fisher exact test). 11 of 20 joints of B-inoculated mice 
and 2 of 20 joints of A-inoculated mice had moderate to se- 
vere inflammation (p <0.01). Only B-inoculated mice had 
severe arthritis. An example of severe arthritis in a mouse 
inoculated with serotype B is shown in Fig. 5. There is a 
mixed inflammation f the synovial lining of the joints and 
tendon sheaths with mononuclear and polymorphonuclear 
cells, and the synovial lining is thickened with several layers 
of ceUs. 
Heart inflammation graded mild or moderate was observed 
in all infected mice but not in the controls. There was not 
a significant difference between serotypes A and B with re- 
spect to the degree of inflammation. The myocarditis was 
characterized by a predominantly mononuclear leukocytic 
infiltrate between myocardial fibers. The inflammation was 
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Figure 5. Histopathology ofjoints ofsc/dmice 
examined 15 d after inoculation ofR tur/catae s ro- 
type B. Paraffin sections were stained with heraa- 
toxylin-eosin. (A) Arrowhead points to general- 
ized thickening of the synovial lining of a tarsal 
joint. Leukocyte and fibrinous e~udate are also 
present in the joint space (x44). (B) Arrowheads 
point to thickened synovial membrane (bottom 
arrow) and exudation ofmixed leukocytes into the 
knee joint space (top arrow) (• 
greatest in the atria and around the base of the great vessels. 
There was also an epicarditis and pericarditis that was most 
marked over the atria and base of the heart. 
Two serotype B-inoculated scid mice were killed when they 
had vestibular disorder; a mouse similarly infected but without 
this disorder was killed at the same time. When their brain 
and middle and inner ears were examined microscopically, 
no evidence of inflammation of these tissues was found. In 
neither these mice nor the group II mice described above were 
there abnormalities ofthe liver, bladder, pancreas, or spleen. 
The testes of both A- and B-inoculated mice contained 
numerous spirochetes in fluid obtained by puncture but no 
leukocytic infiltrate on histologic examination. These histo- 
logic studies demonstrated that serotype A and B differed 
only in the degree of inflammation they caused in the joints. 
Serotype A Is Neurotrapic during Early Infection. The finding 
in the scid mouse xamined after 100 d of infection suggested 
that serotype A was more likely than serotype B to infect 
the brain. To further study this phenomenon 103 cells of the 
"bl00" isolate (Fig. 1), in which only serotype A was detect- 
able, or the "pl00" isolate which was predominantly sero- 
type B, were inoculated into five scid mice each on day 0. 
On day 8 the plasma nd brain were cultured, and the first- 
passage culture harvests were subjected to PAGE for identi- 
fication of the serotype. For this and subsequent experiments 
the blood was obtained first; only after exsanguination a d 
total body perfusion with PBS was the brain taken (33). The 
results of this experiment, the first in this series, are given 
in Table 2. Plasma nd brain cultures from the five mice in 
each group were positive. Mice inoculated with the bl00 iso- 
late had serotype A in both the plasma nd brain. In con- 
trast, the mice inoculated with the pl00 isolate had both sero- 
type A and B in the plasma but only serotype A in the brain, 
even though serotype A represented no more than 10% of 
the inoculum in these mice (Fig. 1). In this and subsequent 
experiments here were, as estimated by number of days in 
culture to reach 106 ceUs/ml, 10-100-fold fewer borrelias per 
volume of brain tissue than in the same volume of plasma. 
In experiment 2 of this part of the study cultures of the 
brain and plasma were taken from scid mice 5-29 (group I) 
inoculated with either serotype A or B and killed on days 
4, 11, and 31. These times represented arly infection (day 
4), arthritis in B- but not A-inoculated mice (day 11), and 
vestibular disorder in A- and B-inoculated mice (day 31). Blood 
cultures were also obtained from the mice on days 18 and 
22. Whereas mice inoculated with serotype A had positive 
plasma nd brain cultures on days 4 and 11, B-inoculated mice 
had positive plasma cultures but negative brain cultures on 
these days (Table 2). The borrelias recovered inthese cultures 
were the same serotypes used to inoculate the animals. 
On day 31 all nine mice had positive brain as well as plasma 
cultures (Table 2). Whereas in A-inoculated mice only sero- 
type A was detectable in blood and brain, B-inoculated mice 
had, besides serotype 13, a new serotype in blood and brain 
on day 31. This new serotype, which was designated C, had 
a Vmp of 21 K (Fig. 6). The representation f serotype C
was higher in brain cultures than in plasma cukures imul- 
taneously obtained. Serotype C was detectable in the plasma 
cultures of only one of the five mice on day 22 and none 
of the mice on day 18 (data not shown). An additional 4 d 
of incubation was required before brain cultures of B-inocuhted 
mice, in comparison to A-inoculated mice, reached a cell den- 
sity of 106/ml. This indicates that there were '~100-fold 
fewer borrdias in the brains of B-inoculated than A-inoculated 
mice examined on day 31. 
Inasmuch as a new serotype, C, appeared in the blood and 
brains of mice inoculated with a clonal population of sero- 
type ]3, it was possible that some scid mice were producing 
Table 2. Cultures of Mice Infected with B. turicatae Serotypes A and B 
Serotype Day 
Exp. inoculated examined 
Serotypes in 
Culture results* culture* 
Plasma Brain Plasma Brain 
1 A + B s 8 5/5 5/5 A, B A 
A 8 5/5 5/5 A A 
2 A 4 4/4 4/4 II A A 
B 4 4/4 0/4 II B - 
A 11 4/4 4/411 A A 
B 11 4/4 0/4 II B - 
A 31 4/4 4/4 A A 
B 31 5/5 5/5 B, C B, C 
3 A + B s 4 4/4 4/4 A, B A 
* Number of mice with positive cultures/number of mice cultured. 
* As determined by electrophoretic migrations of Vmp proteins (see text). 
S A/B, 1:10 in experiment 1 (Fig. 1) and A/B, 1:1 in experiment 3. 
lip = 0.01 by Fisher exact test. 
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Figure 6. Coomassie blue- 
stained proteins of isolates from 
phsma (p) or brain (b) of a mouse 
sampled on days 18, 22, and 31 
after inocuhtion with a clonal 
population of serotype B of R 
aa/catae. For comparison lysates of 
serotype B and A cells are in the 
rightmost two lanes. The samples 
fixnn the plasma were purposefully 
overloaded with respect o the 
brain isolate. The arrow indicates 
a protein of 21 K in the lane of 
p31. This protein is in greater 
amounts in the b31 population. 
The a~'lami& concentration was
12.5%. The migrations of molec- 
ular weight standards (x 1,000) are 
shown on the left. 
Figure 7. Coomassie blue- 
stained protdns of isohtes from 
plasma (p) or brain (b) of two sc/d 
mice (nos. 1 and 2) inoculated 
with a 1:1 mixture of serotypos 
A and B of R tur/cata~ For com- 
parison lysates of erotype A and 
B ceils are in the two leftmost 
hnes. The samples from the brain 
were purposefully overloaded with 
respect to the plasma isohtes. The 
arrows indicate he presence of 
VmpB of 20 K in the plasma iso- 
lates. The acrylamide concentra- 
tion was 12.5%. The migrations 
of molecuhr weight standards 
(x 1,000) are shown on the left. 
specific antibodies (42). To assess this possibility we exam- 
ined sera from scid mice 4, 11, and 31 d after inoculation of 
serotype A or B cells by indirect immunofluorescence. None 
of the sera examined reacted with serotype A or B cells. In 
contrast, the sera from immunocompetent BALB/c mice in- 
oculated with clonal populations of serotype A or B cells 
produced serotype-spedfic antibodies under the same condi- 
tions and in the same assay (data notshown). This was an 
indication that there was not antibody sdection by the scid 
mice against he serotypes originally inoculated. 
One explanation for the presence ofserotype B inthe brain 
by day 31 was that entry into the brain was facilitated by 
prior invasion of a neurotropic serotype. We evaluated this 
possibility by infecting mice with a mixture of donal popu- 
lations of serotype B and serotype A. For this experiment, 
number 3 in the series, four scid mice were infected with 
5 x 103 each of serotype A and B cells on day 0. Plasma 
and brain were obtained and cultured on day 4. The results 
of cultures of two of the mice (nos. 1 and 2) are shown in 
Fig. 7; results with the other two mice were the same (Table 
2). The lanes with lysates of brain cultures from mice nos. 
I and 2 were purposefully overloaded. Serotypes A andB 
were both present in the plasma, but only serotype A was 
detectable in the brain cultures. These findings confirmed that 
entry into the brain in early infection with R turicatae was 
characteristic ofserotype A but not B. Simultaneous inocu- 
lation with a neurotropic serotype did not facilitate arly in- 
fection of the brain by serotype B. 
To evaluate he ability of serotype B to proliferate and sur- 
vive in the brain, 103 borrelias of serotype B were inoculated 
intracerebral!y into three 4-wk-old scid mice. 8 d later plasma 
and perfused brain were obtained from the animals and cul- 
tured. Serotype B was found in both the plasma nd brain 
of all three animals. This experiment showed that serotype 
B has the ability at least to survive in the brain, and, thus, 
its absence from the brains of mice infected peripherally is 
more likely the consequence of lower invasiveness. In this 
respect the culture findings were consistent with the results 
of the in vitro invasion assay. 
Cultures of Joints and Eyes. Borrelias were recovered from 
all perfused tibiotarsal joints taken on day 14 from four A- 
and four B-inoculated mice. The serotype in the culture was 
the same as that used to inoculate the animals. These results 
suggest that serotypes A and B have equal ability to invade 
the joints. Eye cultures were positive from all A- and B-inocu- 
lated mice cultured on days 11 and 31. Inasmuch as the B- 
inoculated mice had negative brain cultures on day 11, the 
access route to the eye was likely the systemic circulation and 
not the subarachnoid space. 
Discussion 
Recent progress in our collective understanding of patho- 
genesis of infectious diseases ha  primarily been at the level 
of the microorganism or the interface between pathogen and 
eukaryotic cell. At one time animal infections were the prin- 
cipal experimental tool of investigators, but now generally 
less is known about he disease itself than about he molec- 
ular and cell biology of the etiologic agent. An impediment 
to reaching a fuller understanding of disease isthe very com- 
plexity of the pathogenic process in an infected animal. Inva- 
sire or otherwise virulent microorganisms u ually employ 
more than one strategy to enter and proliferate in the host 
and subsequently disseminate to n w hosts. Moreover, the 
host responds to the pathogen i a variety of ways, specific 
as well as nonspecific. One way to sort out what is essential 
for virulence is to create mutants that are defective in one 
suspected virulence trait at a time and observe for the amount 
of disease ininoculated animals. This approach has led to the 
identification orconfirmation of a number of virulence factors 
and the genes that encode them. An approach complemen- 
tary to directed mutagenesis is the study of spontaneously 
occurring pathogen polymorphisms for their effects in an- 
imal hosts. Although this type of investigation often begins 
more empiricafiy than directed mutagenesis, t has the ad- 
vantage that manifestations may be qualitatively as weU as 
quantitatively different between variants. When otherwise 
homogeneous populations have two or more alleles for a locus, 
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the different alleles may have been retained because in some 
circumstances proliferation of calls expressing the alternate 
allele is favored. The polymorphisms ay only reflect a shift 
in the population from invaders to colonizers, but there may 
also be more profound ifferences indisease xpression. The 
present study did not start with this second strategy inmind 
but ended showing its benefits. 
The major findings were these: (a) donal populations of 
two serotypes, A and ]3, of R turicatae were similar in their 
ability to infect the blood of mice, to cause myocarditis and 
peripheral vestibular disorder, and to invade the eyes and testes; 
(b) serotype B but not A caused reddening and significant 
swelling of the joints, marked functional impairment on a 
walking bar, and severe arthritis by histologic examination; 
(c) serotype A but not B invaded the brain early in infection; 
and (a') serotype A penetrated monolayers of human umbil- 
ical vein endothelial cells more readily than did serotype B. 
Invasion of the mouse brain by/~ hermsii and R turicatae 
was expected. Other investigators had reported infection of 
the brains of mice by relapsing fever borrelias (18, 43), and 
we recently established that R hermsii nvades the brain and 
cerebrospinal fluid of mice (33). Past investigators had sug- 
gested that certain strains of relapsing fever Borrelia species 
were neurotropic and that others were not (44). These ob- 
servations were made on either different strains or uncloned 
populations of borrdias. In the present study we found that 
serotype A was neurotropic and serotype B was not during 
early infection. In three xperiments, including two in which 
mixed infections were studied, both serotype A and B prolifer- 
ated in the blood, heart, joints, and eye but only serotype 
A was found in the brain for at least 11 d of infection. Sero- 
type A also infected the brain ofimmunocompetent BALB/c 
mice for at least 14 d (Kazragis, R., and A. G. Barbour, un- 
published findings). These results were not attributable to 
a failure of serotype B to grow in the brain. Rather it appears 
to be the consequence of decreased entry of serotype B in 
comparison to A into the central nervous ystem. An in vitro 
correlate of this behavior was comparatively impaired penetra- 
tion of an endothelial cell monolayer by serotype B. By day 
31 serotype B was present in the brain in small numbers, but 
this was only after another serotype, C, had appeared. When 
simultaneous cultures of plasma nd brain were compared, 
there was greater representation f C in the brain, a finding 
that suggests that serotype C is also neurotropic. Although 
R turicatae invaded the brain early and persisted there for up 
to 100 d, there was no apparent inflammation of the brain 
by routine histopathologic examination. 
Neurologic manifestations orcomplications are common 
in both relapsing fever and Lyme borreliosis (1, 12), but there 
have been, to our knowledge, no reports of neurologic dis- 
orders in experimental models of either elapsing fever or Lyme 
borrdiosis. Evidence that the vestibular disorder resulted from 
a VIII cranial neuritis rather than from a central esion or 
otitis were the following: the involvement appeared to be 
limited to the vestibular function and was unilateral, there 
was no evidence of involvement of either the inner ear or 
the brain on pathologic examination, and it was limited in 
duration (31). 
A specific antibody response to either serotype was not 
detected in the scid mice. Although a cell-mediated spedfic 
immune response can not be excluded, previous tudies had 
shown that elimination of R turicatae or R hermsii from the 
blood is a T cell-independent immune response inmice (ref- 
erence 45; A.G. Barbour, unpublished findings). It is likely 
that the resolution of the mucopurulent eye discharge, the 
arthritis, and the vestibular disorder is attributable to non- 
specific host responses. The scid mouse, as well as other labo- 
ratory animals with defined immune delidencies, allows the 
aforementioned complexity of the animal-pathogen interac- 
tion to be reduced for experimental study. 
An unexpected finding of the study was the marked ar- 
thrifts in all mice infected with serotype B; A-inoculated mice 
had only mild to moderate inflammation of the joints that 
produced only minimal functional impairment on the walking 
bar. Arthritis had not been noted as a manifestation rcom- 
plication of relapsing fever in humans or in experimental in- 
fections in animals. In our previous tudies of R hermsii we 
had never observed arthritis in mice, even in scid mice that 
were spirochetemic for weeks (unpublished findings). The 
character and distribution of the arthritis and synovitis were 
very similar to what has been observed in immunodeficient 
mice infected with R burgdo~feri (11). The severity of arthritis 
with R turicatae appears to be the function of the Vmp. Al- 
though there is evidence that OspB of R burgdorferi confers 
some degree of infectivity to that species (46), there has not 
been attribution of the severity of arthritis to a particular 
component inBL burgdorferi. An infectious but nonarthrito- 
genic strain of R burgdorferi has been characterized, but an 
association with a specific protein was not established (47). 
The only discernible difference in components between sero- 
types A and B was their Vmp proteins. Although the popu- 
lation used to infect he first scid mice was not strictly clonal, 
the similarities between the serotype A and B populations 
with respect o protein and restriction enzyme fragment 
profiles indicate that he two populations were isogenic. The 
finding of four other size polymorphisms of the Vmp pro- 
tein suggest that there is a repertoire of vmp genes and that 
variation of this protein in R turicatae has a similar basis to 
that in the closely related species B~ hermsii, which escapes 
immune clearance by multiphasic antigenic variation (35, 48). 
In R hermsii, the Vmp proteins erve as the target for neu- 
tralizing antibody (22, 24), but another function for the pro- 
tein has not been identified. The present study indicates that 
Vmp variability not only confers an ability to escape from 
the immune system but also a mechanism whereby the progeny 
of the founder population could sort out into different niches 
in the host. The differences in pathogen localization and organ 
involvement by R turicatae in scid mice were evidence of this. 
Serotype A invaded the central nervous ystem earlier and 
penetrated ndothelial cell monolayers better than did sero- 
type B. Presumably this invasive capability demonstrated in 
vitro and in vivo was a function of VmpA. On the other 
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hand, VmpB was associated with significantly greater inflam- 
mation of the joints, notwithstanding the apparent equal 
ability of both serotypes to invade the joints. Vmp structure 
may be the proximate determinant of disease xpression in 
this animal model. 
A similar phenomenon was found during studies of the 
reovirus, another neurotropic pathogen. Field et al. (49) found 
that the viral hemagglutinin that determines serotype-speci- 
ficity was also responsible for neurotropic potential and the 
type of nervous ystem disease that occurred. When a type 
1 protein is expressed on the surface, it results in ependymal 
destruction and subsequent hydrocephalus. In contrast, if a 
type 3 protein is expressed, a necrotizing encephalitis with 
neuronal destruction but not ependymal damage occurs. 
Among bacteria the protein II family of proteins of Neisseria 
gonorrhoeae is the example that most dosely resembles what 
we observed with/~ turicatae (50). Protein II antigenic varia- 
tion occurs during infection, and organisms expressing dif- 
ferent protein II variants differ in their adherence to host cells, 
including phagocytic and epithelial ceUs. 
We have up to this point discussed the results primarily 
within the context of borrelias and other infectious agents. 
Reviewing the disorders of the R turicatae infected scid mice, 
we were struck by the similarity of their clinical presentation 
to what has been observed in humans with systemic Lyme 
borreliosis (1). Doubtless there are reasons to defer proposing 
full equivalence between animal model and human disorder: 
the organisms are different species of Borrelia, and the mice 
were immunodeficient. Nevertheless, the R mr/came-infected 
scid mice had more features of systemic Lyme borreliosis than 
have been observed to date in any other laboratory animals 
infected with /g burgdo~feri, even those equivalently im- 
munodeficient (51). In common with animals infected with 
R burgdolferi, the R turicatae-infected animals had myocar- 
ditis, and arthritis. Another similarity with Lyme borreliosis 
is the different stages and remitting course in the mice in- 
fected with R turicatae (52). What the/g turicatae modal 
uniquely offers is a neurologic disorder, consistent and per- 
sistent infection of the brain, and involvement of the eye. 
Of  particular elevance for understanding the pathogenesis 
of the arthritis of Lyme borreliosis was the association of 
marked arthritis with a particular surface protein of the 
borrelia. One of the distinctions between Lyme borreliosis 
in North America and Europe is the infrequency of chronic 
arthritis in northern and eastern Europe (1, 53). This differ- 
ence in disease xpression may be the consequence of differ- 
ences between the local etiologic agents (54). The invasion 
of and persistence in the brain by R turicatae may also have 
relevance for studies of other chronic spirochetal diseases of 
the nervous ystem, syphilis, and the phenomenon of neu- 
rotropism in general. 
We thank Julie Rawllngs and Jeff Taylor for providing R turicatae, Catherine Luke and Stephanie Cote 
for advice, and Robin Brey and Alien Steere for critical reviews of the manuscript. 
This work was supported by United States Public Health Service grants AI-24424 and AI-29731 to 
A. G. Barbour and AI-26804 to D. D. Thomas. 
Address correspondence to Alan G. Barbour, Department of Microbiology, The University of Texas Health 
Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78284-7758. 
Received for publication 8July 1993 and in revised form 29 September 1993. 
References 
1. Steere, A. 1989. Lyme disease. N. Engl. J. Med. 321:586. 
2. Schaible, U., M. Kramer, R. WaUich, T. Tran, and M. Simon. 
1991. Experimental Borrd/a bur&dorfai infection in inbred mouse 
strains: antibody response and association of H-2 genes with 
resistance and susceptibility o development of arthritis. Eur. 
f lmmunoL 21:2397. 
3. Steere, A., E. Dwyer, and R. Winchester. 1990. Association 
of chronic Lyme arthritis with HLA-DR4 and HLA-DK2 al- 
leles. N. Engl. f Med. 323:219. 
4. Barthold, S., D. Beck, G. Hansen, G. Terwilliger, and K. 
Moody. 1990. Lyme borreliosis in sdected strains and ages of 
laboratory mice. f Infect. Dis. 162:133. 
5. Pachner, A., and A. Itano. 1990. Borrdia hrgdorferi infection 
of the brain: characterization f the organism and response 
to antibiotics and immune sen in the mouse model. Neurolog 7. 
40:1535. 
6. Barthold, S., K. Moody, G. Terwilliger, E Duray, R. Jacoby, 
and A. Steere. 1988. Experimental Lyme arthritis in rats in- 
fected with Borrelia burgdo~ferl. J. Infect. Dis. 157:842. 
7. Johnson, K., N. Marek, and C. Kodner. 1984. Infection of 
Syrian hamsters with Lyme disease spirochetes.f Clin. MicrobioL 
20:1099. 
8. Komblatt, A., A. Steere, and D. Brownstein. 1984. Experi- 
mental Lyme disease inrabbits: spirochetes found in erythema 
migrans and blood. Infect. Immun. 46:220. 
9. Preac Mursic, V., E. PatsourLs, R W'tlske, S. Reinhardt, 13. Gross, 
and P. Mehraein. 1990. Persistence ofBorrelia burgdo~feri and 
histopathological alterations in experimentally infected animals. 
A comparison with histopathological findings in human Lyme 
disease. Infection. 14:332. 
10. Defosse, D., P. Duray, and R. Johnson. 1992. The NIH-3 im- 
mtmodefident mouse is a model for Lyme borreliosis myositis 
and carditis. Am. J. PathoL 141:3. 
11. Sehaible, U., S. Gay, C. Museteanu, M. Kramer, G. Zimmer, 
K. Eichmann, U. Museteanu, and M. Simon. 1990. Lyme bor- 
reliosis in the severe combined immunodeficiency (scic 0 mouse 
manifests predominantly in the joints, heart, and liver. Am. 
J. Pathol. 137:811. 
641 Cadavid etal. 
12. Southern, E, and J. Sanford. 1969. Relapsing fever. Medicine 
(Baltimore). 48:129. 
13. Barbour, A., and S. Hayes. 1986. Biology of Borrelia species. 
Micrabiol. Reviews. 50:381. 
14. Barbour, A. 1990. Antigenic variation of a relapsing fever 
Borrel/a species. Annu. Rev. Microbiol. 44:155. 
15. Bergeret, C., and A. Raoult. 1948. Notes sur les formes ner- 
veuses de la fievre recurrente-Fievre recurrente a tiques en 
Afi'ique Occidentale Francaise. Bulletin Medicale Afiique Occiden- 
tale Franca/s~ 5:271. 
16. Taft, W., andJ. Pike. 1945. Re, lapsing fever. Report of a sporadic 
outbreak including treatment with penicillin.JAMA (.J. Am. 
Med Asso~). 129:1002. 
17. Levaditi, C., and T. Anderson. 1928. Nenrotropisme du Spiro- 
chaeta duttoni. Comptes Reudus. Academie des Sciences. 186:653. 
18. Buschke, A., and H. Kroo. 1922. Experimental recurrentis in- 
fection. Klin. Wochenshr. 1:2470. 
19. Sergent, E. 1945. Persistentce d Spirochaete hispanica pendant 
trois ans duns le cerveau d'un cobaye. 3e note. Arch. Inst. Pasteur 
Alg~ 23:245. 
20. Hiroki, H. 1932. Experimentelle untersuchung ueber die per- 
sistenz der recurrensspirochaeten im gehirn. I. Miteihng: ueber 
die grundlegenden u tersuchung mit dem mandschurischen 
recurrensspirochaeten, f Oriental Med. 17:11. 
21. Burgdorfer, W. 1959. Zum organotropismus der spirochaete 
~R duttoni gegenuber der ubezt~agenden zecke. Acta. Trop 16:242. 
22. Barbour, A.G., S.L. Tessier, and H.G. Stoenner. 1982. Variable 
major proteins of Borrelia hermsii. J Exit Med. 156:1312. 
23. Taylor, J  G. Moore, andJ. Cheek. 1991. Outbreak of relapsing 
fever masquerading as Lyme borreliosis. 30th Interscience Con- 
ference on Antimicrobial Agents and Chemotherapy (ICAAC). 317. 
(Abstr.) 
24. Stoenner, H.G., T. Dodd, and C. Larsen. 1982. Antigenic vari- 
ation of Borrelia hermsii. J Exit Med. 156:1297. 
25. Greenberg, E., and E. Canale-Parola. 1977. Chemotaxis in 
Spirochaeta aurantia, f Bacteriol. 130:485. 
26. Barbour, A. 1984. Isolation and cultivation of Lyme disease 
spirochetes. Yale f Biol. Med. 57:521. 
27. Sadziene, A., P.A. Rosa, P.A. Thompson, D.M. Hogan, and 
A.G. Barbour. 1992. Antibody-resistant mutants of B0rrel/a burg- 
dorferi: in vitro selection and characterization, f Exit Med. 
176:799. 
28. Meier, J., M. Simon, and A. Barbour. 1985. Antigenic varia- 
tion is associated with DNA rearrangements i  a relapsing fever 
borrelia. Cell. 41:403. 
29. Jaffe, E., R.. Nachman, C. Becket, and R. Minick. 1972. Cul- 
ture of human endothelial cells derived from human umbilical 
cord veins. Circulation. 46:211. 
30. Comstock, L., and D. Thomas. 1989. Penetration f endothelial 
cell monolayers by Borrelia burgdotferi. Infect. Immun. 57:1626. 
31. Simpson, S. 1988. Ataxia, head tilt, nystagsnus, circling, and 
hemiparesis. In Clinical Signs and Diagnosis in Small Animal 
Practice. R.R Ford, editor. Churchill Livingstone, New York. 
257. 
32. Sakic, B., H. Szechtman, M. Keffer, H. T~h-gbayan, R. Stead, 
and J. Denbur. 1992. A behavioral profile of autoimmune hpos- 
prone MRL mice. Brain Behau lmmun. 6:265. 
33. Cadavid, D., V. Bundoc, and A. Barbour. 1993. Experimental 
infection of the mouse brain by a relapsing fever Borrel/a spe- 
cies: a molecular analysis, f Infect. Dis. 168:143. 
34. Stover, C.L., G.P. Bansal, M.S. Hanson, J.E. Burlein, S.R. 
Palaszynski, J.E Young, S. Koenig, D.B. Young, A. Sadziene, 
and A.G. Barbour. 1993. Protective immunity elicited by recom- 
binant bacille Calmette-Guegin (BCG) expressing outer sur- 
642 
face protein A (OspA) lipoprotein: acandidate Lyme disease 
vaccine. J. Exit IVied. 178:197. 
35. Restrepo, R, T. Kitten, C. Carter, D. Infante, and A. Bar- 
bour. 1992. Subtelomeric expression regions ofBorrelia hermsii 
linear plasmids are highly polymorphic. Mol. Microbiol. 6:3299. 
36. Wilske, B., A. Barbour, S. Bergstrom, N. Burman, B. Res- 
trepo. P. Rosa, T. Schwan, E. Soutschek, and R. Wallacli. 1992. 
Antigenic variation and strain heterogeneity in Boml/a spp. 
Res. Microbiol. 143:583. 
37. Randall, L., and S. Hardy. 1986. Correlation of competence 
for export with lack of tertiary structure of the mature spe- 
cies: a study in vivo of maltose-binding i  E. coll. Cell. 46:921. 
38. Luft, B., W. Jiang, p. Munoz, R. Dattwyler, and P. Gorevic. 
1989. Biochemical nd immunochemical haracterization f 
the surface proteins ofBorrc//a burgdorfe6. Infect. lmraun. 57:3637. 
39. Barstad, P.A., J.E. Coligan, M.G. Raum, and A.G. Barbour. 
1985. Variable major proteins ofBorrelia herrasii. Epitope map- 
ping and partial sequence analysis of CNBr Peptides. J. Ext~ 
Med. 161:1302. 
40. Schuhardt, V., and M. Wilkerson. 1951. Relapse phenomena 
in rats infected with single spirochetes (Borrelia recurrentis war. 
turicatae). J. Bacteriol. 62:215. 
41. Dean, R., J. Scozzafava, J. Goas, B. Regan, R Beer, and R. 
Bartus. 1981. Age-related differences in behavior across the life 
span of the C57BL/6J mouse. Exp. Ageing Res. 7:427. 
42. Nonoyama, S., E Smith, I. Bernstein, and H. Oclis. 1993. 
Strain-dependent leakiness of mice with severe combined im- 
mune deficiency. J. Immunol. 150:3817. 
43. Coleman, G. 1933. Relapsing fever in California. I. The ex- 
perimental disease. J. Infect. Dis. 53:337. 
44. Pirot, R., and M. Bourgain. 1945.12infection latente residuale 
cerebrale chez le cohaye au cours des recurrentes a Spirochaeta 
persica. La survie du spirochete dans l'encephale est function 
de facteurs individuels. Bull. So~ Pathol. Fil. 38:12. 
45. Newman, K., and R. Johnson. 1984. T-cell-independent elimi- 
nation of Borrelia turicatae. Infect. lraraun. 45:572. 
46. Sadziene, A., A. Barbour, P. Rosa, and D. Thomas. 1993. An 
OspB mutant of Borrelia burgdorfe6 has reduced invasiveness 
in vitro and reduced infectivity in vivo. Infect. Imraun. 61:3590. 
47. Anderson, J., S. Barthold, and L. Magnarelli. 1990. Infectious 
but not pathogenic isolate ofBorrel/a burgdorferi.J. Clin. Microbiol. 
28:2693. 
48. Kitten, T., and A. Barbour. 1990. Juxtaposition of expressed 
variable antigen genes with a conserved telomere in the bacte- 
rium Borrelia hermsii. Pro~ Natl. A_caR Sci. USA. 87:6077. 
49. Weiner, H., D. Drayna, D. Averill, and B. Fields. 1977. Mo- 
lecular basis of reovirus virulence: role of the S1 gene. Pro~ 
Natl. Acad. &i. USA. 74:5744. 
50. Cannon, J. 1988. Genetics of Protein II ofNe/sser/a gonorrhoeae. 
In Bacteria-Host Cell Interaction. M.A. Horwitz, editor. Alan 
R. Liss, Inc., New York. 393. 
51. Schaible, U.E., M.D. Kramer, C Museteanu, G. Zimmer, H. 
Mossmann, and M.M. Simon. 1989. The severe combined im- 
munodeficiency (scid) mouse. A laboratory model for the anal- 
ysis of Lyme arthritis and carditis, f Exit Med. 170:1427. 
52. Steere, A., R. Schoen, and E. Taylor. 1987. The clinical evolu- 
tion of Lyme arthritis. Ann. Intern. Med. 107:725. 
53. Blaauw, A., M. Nohlmans, P. Leffers, H. Goei The, and S. 
Van del Linden. 1992. Lyme borreliosis: a very infrequent cause 
of arthritis of undetermined aetiology in the southern part of 
the Netherhnds. Br. J. Rheum. 31:401. 
54. Barbour, A., and D. Fish. 1993. The biological and social 
phenomenon ofLyme disease. Science (Wash. DC). 260:1610. 
Borrdial Surface Proteins and Disease Expression 
